Soligenix, Inc.: valuation
What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.
Cash-flow value
Fewer than two of the last three years have both cash from operations and capital spending on file.
Your own DCF model
A full discounted-cash-flow model of Soligenix, Inc., started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.
Open the DCF modelAgainst the industry Biotechnology
Multiples of its companies with a market value at most 60 days old, times Soligenix, Inc.'s own figures of FY2025.
| Multiple | Peers (25th / median / 75th) | Soligenix, Inc. | Applied to | Value (25th to 75th) | Companies |
|---|---|---|---|---|---|
| Price to book | 3.1× / 4.5× / 12.3× | 1.6× | book equity $5 M | $16 M to $65 M | 70 |
Peers' multiples from the distributions by industry; the company's figures from its statements below. A multiple says what similar companies cost, not what this one is worth.
The statements it starts from
USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.
| Fiscal year | Revenue | Net income | Cash from operations | Capital spending | Free cash flow | Net debt | Source |
|---|---|---|---|---|---|---|---|
| FY2025to Dec 31, 2025 | — | $-11 M | $-10 M | $0 M | $-10 M | — | SEC annual report (10-K, 20-F) |
| FY2024to Dec 31, 2024 | — | $-8 M | $-8 M | — | — | $-8 M | SEC annual report (10-K, 20-F) |
| FY2023to Dec 31, 2023 | $1 M | $-6 M | $-9 M | — | — | $-7 M | SEC annual report (10-K, 20-F) |
| FY2022to Dec 31, 2022 | $1 M | $-14 M | $-13 M | — | — | $-13 M | SEC annual report (10-K, 20-F) |
| FY2021to Dec 31, 2021 | $1 M | $-13 M | $-12 M | — | — | — | SEC annual report (10-K, 20-F) |
| FY2020to Dec 31, 2020 | $2 M | $-18 M | $-11 M | — | — | — | SEC annual report (10-K, 20-F) |
Each figure as filed; the full statements with every line and its filing are on the company page. Market value $9 M on Oct 30, 2026.
How it is worked out: the cash-flow value is free cash flow grown at the first-stage rate for the years chosen, then at the long-run rate for ever, each year discounted at the risk-free rate plus the equity risk premium, less net debt. What the price assumes is the first-stage growth that makes that value equal today's market value. The starting cash flow, growth and net debt come from the statements; the risk-free rate from the US Treasury; the premium and the long-run growth are assumptions and are labelled so. This is arithmetic on reported figures, not advice.